Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
The multiple-dose pharmacokinetics and safety of ciprofloxacin, a new quinoline carboxylic acid derivative, were evaluated in normal volunteers. The drug was administered orally every 12 h during successive 7-day periods at doses of 250, 500, and 750 mg. Samples of serum, urine, and saliva obtained...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1984
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180005/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6517556/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.5.741 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
